Full Text View
Tabular View
No Study Results Posted
Related Studies
Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR-DMD)
This study is currently recruiting participants.
Verified February 2013 by University of Rochester
Study NCT01603407   Information provided by University of Rochester

First Received on April 3, 2012.   Last Updated on February 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Duchenne Muscular Dystrophy
Additional conditions recognized in this trial
Muscular Dystrophies
Muscular Dystrophy, Duchenne
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
Prednisone
Deflazacort
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Rochester
Newcastle University
University Medical Center Freiburg
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services